Sign in
4

Changes in Ownership

NRX Pharmaceuticals, Inc. Filed Acc 0001415889-22-011810

Director bought 11,750 shares at an average $1.25 ($14,663)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Flynn Patrick John Director 2022-11-28 Purchase +2,500 $1.25 $3,125 37,709 I
Flynn Patrick John Director 2022-11-28 Purchase +2,500 $1.25 $3,125 40,209 I
Flynn Patrick John Director 2022-11-28 Purchase +2,500 $1.25 $3,125 37,709 I
Flynn Patrick John Director 2022-11-28 Purchase +2,500 $1.24 $3,100 40,209 I
Flynn Patrick John Director 2022-11-28 Purchase +1,750 $1.25 $2,188 1,750 D
Open-market purchases · 11,750 sh · avg $1.25 · $14,663
Loading xslF345X03/form4-11292022_071101.xml…